Skip to main content
. 2021 Nov 1;10(Suppl 2):S62–S74. doi: 10.1002/sctm.20-0495

TABLE 1.

Umbilical cord blood transplantation for acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and aplastic anemia (AA)

References Diagnosis Patients (n) Graft" Median age, years (range) Neutrophil engraftment Platelet engraftment (≥20 × 109/L) Relapse TRM Grade II‐IV Acute GVHD Chronic GVHD Overall survival Disease‐free survival
Matsumura et al 7 ALL 256 Single unit 40 (16‐74) 78% at day 100 64% at day 100 43% at 2 years 35% 37% 24% at 2 years 42% at 2 years 36% at 2 years
Page et al 8 ALL 640 Single unit 6.4 (0.5‐17.9) / / 26% / 40.4% 17% at 5 years 51.3% at 5 years 47.4% at 5 years
Piñana et al 9 PH + ALL 45 Single unit 31 (3–47) 96% at 44 days 73% at 183 days 31% at 5 years 31%(18%–45%) at 5 years 31% 53% (36‐70%) at 5‐years 44% (28‐60%) at 5 years 36% at 5 years
Sanz et al 10 High‐risk AML 49 Single unit 34 (16‐52) 96% at 57 days 73% at 250 days 19% at 2 years 2‐year NRM: 39% 26% 46% at 2 years 37% at 4 years
Baron et al 11 AML 1068 Single unit: 567, double units: 501 45.5 (18‐73) 77% / 32% at 2 years 38% at 2 years 31% 42% at 2 years 32% at 2 years 30% at 2 years
Yanada et al 12 AML 1355 Single unit 52 (16‐85) / / 18.2% at 3 years 29.5% at 3 years / / 55.1% at 3 years /
Madureira et al 13 MDS 70 Single unit 6 (<1‐17) 76% at day 60 57% at day 180 13 of 70 53% prior to 2001 (n = 30); 31% after 2001 (n = 40) 30% 23% at 3 years 42% at 3 years 39% at 3 years
Robin et al 14 MDS 129 Single unit: 49, Double units: 80 57 (20‐72) 78% / 30% 42% at 2 years 31% 23% 30% 28% ± 4%
Gerds et al 15 MDS 176 Single unit: 36, double units: 140 56 (18–73) / / 32% at 3 years 40% at 3 years 38% at 3 years 28% at 3 years 31% at 3 years 28% at 3 years
Kuwatsuka et al 16 SAA 69 Single unit 49 (17‐73) 71% at day 42 / / / 32%, 21% at 3 years 69% at 3 years /
de Latour et al 17 SAA 26 Single unit: 16, double units: 10 16 (9‐23) / / / 11.5% at 1 year 45.8% 36% at 1 year 88.5% at 1 year /
Yoshimi et al 18 SAA 31 Single unit 27.9 (0.8‐72.7) 54.8 72.2% / / 17.1% 19.7% 41.1% at 2 years /
HHS Vulnerability Disclosure